FindTrial
Sign In

A prospective observational study for interstitial pneumonia with autoimmune features

A prospective observational study for interstitial pneumonia with autoimmune features

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023556
Enrollment
Unknown
Registered
2019-06-02
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial pneumonia with autoimmune features

Interventions

Case series:None

Sponsors

Yantai Yuhuangding Hospital Affiliated to Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Interstitial pneumonia with autoimmune features patients meet the 2015 ATS/ ERS statement; 2. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Have active malignant tumors and/or diseases of the blood system; 3. Suffering from serious uncontrolled diseases of other systems.

Design outcomes

Primary

MeasureTime frame
clinical features;Disease progression;mortality;biomarkers;—

Secondary

MeasureTime frame
Identify the risk factors of IPAF progression to CTD-ILD;—

Countries

China

Contacts

Public ContactYishan Mao

Yantai Yuhuangding Hospital Affiliated to Qingdao University

dcmqs@163.com+86 13723983978

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026